Main Street Law Firm is no longer accepting acid reflux drug cases. If you feel that you may have a case, we urge you to contact another firm suited to handle your case.
Main Street Law Firm is no longer accepting Allergan textured implant cases. If you feel that you may have a case, we urge you to contact another firm suited to handle your case.
Main Street Law Firm is no longer accepting Essure birth control cases. If you feel that you may have a case, we urge you to contact another firm suited to handle your case.
Main Street Law Firm is no longer accepting hip replacement cases. If you feel that you may have a case, we urge you to contact another firm suited to handle your case.
Main Street Law Firm is no longer accepting Camp Lejeune cases. If you feel that you may have a case, we urge you to contact another firm suited to handle your case.
The Main Street Law Firm is no longer taking new cases in this matter.
Other Military Cases:
Between 2003 and 2015, 3M manufactured the Dual-Ended Combat Arms™ Earplugs that were distributed to thousands of military personnel. In a recent settlement agreement with the United States Department of Justice, 3M agreed to pay $9.1 million to resolve allegations that they knowingly sold defective earplugs to the U.S. military. These settlement proceeds will not be distributed to military personnel. Our law firm, along with experienced referral law firm partners, are pursuing civil lawsuits to obtain compensation for hearing loss damages.
Research has found evidence that links a common firefighting foam with the development of cancer in its users. Those that have been exposed to the dangerous chemicals by ingesting them orally, absorbing them through the skin, or inhaling them through the air are at risk of developing various types of cancer. If you are a veteran of a military base or a resident who lived near a military base and subsequently developed cancer from exposure to the firefighting foam, fill out our free case review to see if you are eligible for compensation without ever going to court.
Other Military Cases:
If you or a loved one are a U.S. military service member, veteran, or military contractor who suffered injuries from certain explosive terrorist devices between 2003 and 2011, you may have a claim for significant damages without ever going to court and even if you are already receiving disability or other compensation.
Research has found evidence that links a common firefighting foam with the development of cancer in its users. Those that have been exposed to the dangerous chemicals by ingesting them orally, absorbing them through the skin, or inhaling them through the air are at risk of developing various types of cancer. If you are a veteran of a military base or a resident who lived near a military base and subsequently developed cancer from exposure to the firefighting foam, fill out our free case review to see if you are eligible for compensation without ever going to court.
Xeljanz Linked to Increased Risk of Blood Clots and Death
If you or a loved one have experienced injuries while taking Xeljanz or Xeljanz XR, you may be entitled to significant compensation without ever going to court. Fill out the intake form on this page for a free, no-obligation review of your case and to find out how we might be able to help.
FDA issues black box warning for 10 mg dosage
Tofacitinib, more commonly known as Xeljanz or Xeljanz XR, was first approved by the U.S. Food and Drug Administration (FDA) in 2012 and is used to treat rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ulcerative colitis. The drug is available in 5 and 10 mg tablets and works by decreasing the activity of the immune system (an overactive immune system contributes to RA, PsA, and ulcerative colitis).
On July 26, 2019, the FDA approved new warnings for the 10 mg twice daily dose of Xeljanz & Xeljanz XR, the dosage approved to treat ulcerative colitis, over an increased risk of blood clots and death. The warning was added after the FDA reviewed data from an ongoing safety clinical trial of the drug. An analysis of the trial’s results found an increased occurrence of blood clots and death in patients taking the 10 mg twice daily dosage compared to those treated with the 5 mg twice daily dosage or a TNF blocker. The safety trial is ongoing, and the FDA says they will reassess these concerns when it is completed and final, verified data is available.
What you should do if you are currently taking Xeljanz or Xeljanz XR
If you are currently taking Xeljanz or Xeljanz XR, do not stop taking it without first talking to your healthcare professional. Let your health care professional know if you have a history of blood clots or heart problems, or if you have any other questions or concerns. If you are experiencing any unusual symptoms, seek medical attention immediately. Symptoms signaling a blood clot include:
- Chest pain
- Sudden shortness of breath
- Difficulty breathing
- Coughing up blood
- Swelling or pain in your leg or arm
- Red or discolored skin
- Lower leg cramp
Find out if you could qualify for compensation
If you or a loved one have experienced injuries while taking Xeljanz or Xeljanz XR, we’re here to help. You may be entitled to significant compensation without ever going to court. Fill out the intake form on this page for a free, no-obligation review of your case.
